Doximity Inc

Doximity Inc(DOCS)股票分析

$30.970

-0.520 (-1.68%)收盤時

Loading chart…
最高
32.110
開盤
31.970
成交量加權均價
31.22
成交量
3.58M
市值
5.16B
最低
30.590
成交金額
111.87M
企業價值/稅息折舊攤銷前利潤(TTM)
31.21

Doximity, Inc. operates as a digital platform for United States medical professionals. The Company provides an online platform which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers primarily include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Its marketing solutions provide customers to share content on the network. Its hiring solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates. Its Workflow solutions allow customers to initiate voice and video calls with patients and manage on-call scheduling.

AI 分析 of Doximity Inc (DOCS)

持有

Doximity is currently trading at $30.97, which is above its 5-day simple moving average of $30.70 and its Fibonacci pivot level of $29.79, indicating short-term strength. However, the stock has a high forward P/E ratio of 19.76, suggesting it may be overvalued relative to its earnings potential. Additionally, insider selling has increased by 474.47% recently, which raises concerns about insider confidence. Given these factors, while there are some positive indicators, the risks associated with insider selling and the class action lawsuits make it prudent to hold rather than buy at this time.

估值指標

Doximity Inc(DOCS)目前預期本益比為 19.76,5 年平均預期本益比為 43.87。

預期本益比

低估
5 年均值 P/E
43.87
目前P/E
19.76
高估
67.95
低估
19.78

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
29.51
目前EV/EBITDA
31.21
高估
44.85
低估
14.16

預期股價營收比

低估
5 年均值 P/S
14.15
目前P/S
7.77
高估
20.33
低估
7.96

Alphio AI 對 DOCS 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%DOCS

$68.82

情境價格

基

基準

基準 · 50%DOCS

$57.86

情境價格

悲

悲觀

悲觀 · 25%DOCS

$53.68

情境價格

持有 DOCS 的大戶

C

Carmignac Gestion SA

+ 持有DOCS

+5.97%

3個月報酬率

F

Fundsmith, LLP

+ 持有DOCS

+4.73%

3個月報酬率

事件時間軸

2026-10-13 (ET)

05:30:00

Doximity Extends Partnership with U.S. News & World Report

2026-08-10 (ET)

17:00:00

Stocks Open Lower as Middle East Uncertainty Grows

12:30:00

Major Averages Mixed at Open Amid Middle East Uncertainty

2026-08-07 (ET)

12:30:00

Doximity Stock Rises 36.2% to $28.14

10:30:00

Doximity Stock Rises 55.8% to $32.19

資訊

DOCS 常見問題 —— 由 Alphio AI 解答

Doximity, Inc. operates as a digital platform for United States medical professionals. The Company provides an online platform which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers primarily include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Its marketing solutions provide customers to share content on the network. Its hiring solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates. Its Workflow solutions allow customers to initiate voice and video calls with patients and manage on-call scheduling. It operates in the Technology sector (SERVICES-COMPUTER PROGRAMMING SERVICES industry).

Doximity is currently trading at $30.97, which is above its 5-day simple moving average of $30.70 and its Fibonacci pivot level of $29.79, indicating short-term strength. However, the stock has a high forward P/E ratio of 19.76, suggesting it may be overvalued relative to its earnings potential. Additionally, insider selling has increased by 474.47% recently, which raises concerns about insider confidence. Given these factors, while there are some positive indicators, the risks associated with insider selling and the class action lawsuits make it prudent to hold rather than buy at this time.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易